Lack of drug preparations for use in children in Brazil

Jornal de Pediatria

Volumn 85, Issue 3, 2009, Pages 229-235

  Da Costa, Patrícia Quirino ^a   Coelho, Helena Lutéscia L ^a,b   Rey, Luis C ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b UFC ^*  (Brazil)

Author keywords

Dose forms; Medication errors; Pediatric formulations; Pediatrics; Pharmaceutical preparations; Pharmacoepidemiology; Use of medications

Indexed keywords

ACETAZOLAMIDE; ALLOPURINOL; AMILORIDE; ATROPINE; AZITHROMYCIN; BETHANECHOL; CAFFEINE; CANDESARTAN; CETYLPYRIDINIUM SALT; CHLORAL HYDRATE; CIPROFLOXACIN; CYCLIZINE; DICLOFENAC; DIHYDROCODEINE; DIHYDROERGOTAMINE; ECHINACEA PURPUREA EXTRACT; ETIRACETAM; FRAMYCETIN; MALATHION; NICARDIPINE; NOSCAPINE; PENICILLIN G; PIPENZOLATE BROMIDE; PYRIDOXINE; SUCCIMER; SULTIAME; TYROTHRICIN; UNINDEXED DRUG; UROKINASE; URSODEOXYCHOLIC ACID;

ARTICLE; BRAZIL; DESCRIPTIVE RESEARCH; DRUG CLASSIFICATION; DRUG FORMULATION; DRUG INDICATION; DRUG INDUSTRY; DRUG LABELING; DRUG USE; LICENSING; MEDICATION ERROR; REFERENCE DATABASE;

BRAZIL; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; LICENSURE; OFF-LABEL USE; PHARMACEUTICAL PREPARATIONS;

EID: 67049096208     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/JPED.1896     Document Type: Article

References (38)

1. Chalumeau M, Tréluyer JM, Salanave B, Assathiany R, Chéron G, Crocheton N, et al. Off label and unlicensed drug use among French office based paediatricians. Arch Dis Child. 2000;83:502-505
2. McIntyre J, Conroy S, Avery A, Corns H, Choonara I. Unlicensed and off label prescribing of drugs in general pratice. Arch Dis Child. 2000;83:498-501.
3. Dick A, Keady S, Mohamed F, Brayley S, Thomson B, Lloyd BW, et al. Use of unlicencesed and off-labell medications in paediatric gastroenterology with a review of commonly used formularies in the UK. Aliment Pharmacol Ther. 2003;17:571-575 (Pubitemid 36384816)
4. 't Jong GW, Eland IA, Sturkenboom MC, van den Anker JN, Stricker BH. Determinants for drug prescribing to children below the minimum licensed age. Eur J Clin Pharmacol. 2003; 58: 701-705
5. Stephenson T. The medicines for children agenda in the UK. Br J Clin Pharmacol. 2006;61:716-719 (Pubitemid 43794799)
6. Duarte D, Fonseca H. Melhores medicamentos em pediatria. Acta Pediat Port. 2008;39:17-22.
7. World Health Organization. Make medicines child size. http://www.who.int/childmedicines/en. Access: 18/01/2009.
8. Boots I, Sukhai RN, Klein RH, Holl RA, Wit JM, Cohen AF, et al. Stimulation programs for pediatric drug research - do children really benefit? Eur J Pediatr. 2007; 166:849-855
9. Meiners MM, Bergsten-Mendes G. Prescrição de medicamentos para crianças: como avaliar a qualidade. Rev Assoc Med Bras. 2001;47:332-337
10. Carvalho PR, Carvalho CG, Alievi PA, Martinbiancho J, Trotta EA. Identificação de medicamentos "não apropriados para crianças" em prescrições de unidade de tratamento intensivo. J Pediatr (Rio J). 2003;79:397-402.
11. Peterlini MA, Chaud MN, Pedreira ML. Órfãos da terapia medicamentosa: a administração de medicamentos por via intravenosa em crianças hospitalizadas. Rev Latino-Am Enfermagem. 2003;11:88-95.
12. dos Santos DB, Coelho HL. Adverse drug reactions in hospitalized children in Fortaleza, Brazil. Pharmacoepidemiol Drug Saf. 2006;15:635-640
13. Santos DB, Clavenna A, Bonati M, Coelho HL. Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil. Eur J Clin Pharmacol. 2008;64:1111-1118
14. Royal Pharmaceutical Society of Great Britain. BNF for children. London: BMJ Publishing; 2007.
15. Thompson DF, Heflin NR. Frequency and appropriateness of drug prescribing for unlabeled uses in pediatric patients. Am J Hosp Pharm. 1987;44:792-796 (Pubitemid 17052463)
16. a. ed. São Paulo: Publicações Científicas, 2005/2006.
17. a. ed. São Paulo: Publicações Científicas; 2006/2007.
18. Governo do Estado do Ceará. Secretária de Saúde. Núcleo de Assistência Farmacêutica. Formulário terapêutico. Fortaleza; 2002.
19. Brasil. Ministério da Saúde. Agência Nacional de Vigilância Sanitária. Bulário. Brasília; 2005. http://www.anvisa.gov.br/medicamentos/bulas/index.htm. Access: 16/02/2009.
20. Centralx. Bulas de medicamentos na Internet. http://www.bulas.med.br/ index. Access: 20/02/2009.
21. Costa PQ, Coelho HL, Lima JE. Prescrição e preparo de medicamentos sem formulação adequada para crianças: um estudo de base hospitalar. Rev Bras Cienc Farmac. No prelo 2009.
22. World Health Organization. WHO Collaborating Centre for Drug Statistics Methodology. ATC Index 2004. http://www.whocc.no/atcddd. Access: 18/02/2009
23. Taketomo CK, Hodding JH, Kraus DM. Pediatric dosage handbook. 8th ed. Chicago, IL: Lexi-Comp; 2002.
24. Brasil. Ministério da Saúde. Agência Nacional de Vigilância Sanitária. Fundamentos farmacológico- clínicos dos medicamentos de uso corrente [CD-ROM]. Brasília: MS; 2002.
25. Turner S, Gill A, Nunn AJ, Hewitt B, Choonara I. Use of "off label" and unlicensed drugs in paediatric intensive care unit. Lancet. 1996;347:549-550 (Pubitemid 26061633)
26. Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ. 1998;316:343-345 (Pubitemid 28121257)
27. Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed. 1999;80:F142-5.
28. Conroy S, Choonara I, Impicciatorre P, Mohn A, Arnell H, Rane A, et al. Survey of unlicensed and off label drug use paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ. 2000;320:78-82
29. Fontan JE, Combeau D, Brion F. Lês préparations pédiatriques dans lês hôspitaux français. Arch Pediatr. 2000;7:825-832
30. Gavrilov V, Lifshits M, Levy J, Gorodischer R. Unlicensed and off label medication use in a general pediatrics ambulatory hospital unit in Israel. Isr Med Assoc J. 2000;2:595-597
31. Conroy S, Peden V. Unlicensed and off label analgesic use in paediatric pain mangement. Pediatr Anaesth. 2001;11:431-436 (Pubitemid 32635321)
32. Lifshitz M, Gavrilov V, Gorodischer R. Off label and unlicensed use off label antidotes in paediatric patients. Eur J Clin Pharmacol. 2001;56:839-841 (Pubitemid 33788557)
33. Lifshitz M, Gavrilov V, Grossman Z, Binsthok N, Homik D, Rosemblun H, et al. Unapproved prescription pratices in primary pediatric clinics in Israel: a prospective analysis. Curr Therap Res. 2002;63:830-837 (Pubitemid 36092344)
34. Conroy S, Newman C, Gudka S. Unlicensed and off label drug use in acute lymphoblastic leukaemia and other malignancies in children. Ann Oncol. 2003;14:42-47 (Pubitemid 36150257)
35. Loder EW, Biondi DM. Off-label prescribing of drugs in specialty headeache pratice. Headache. 2004;44:636-641 (Pubitemid 38931893)
36. Bonati M. Epidemiologic evaluation of drug use in children. J Clin Pharmacol. 1994;34:300-305 (Pubitemid 24138960)
37. Brasil. Ministério da Saúde. Agência Nacional de Vigilância Sanitária. RE 530, de 17 de abril de 2001. Cancela o registro de medicamentos a base de cisaprida. http://e-legis.bvs.br/leisref/ public/home.php. Access: 28/01/2009.
38. Osório de Castro CG, Castilho SR. Diagnóstico da farmácia hospitalar no Brasil. Rio de Janeiro, RJ: ENSP/ Fiocruz; 2004. p.135-138